HRSV genotype | NA1 | ON1 | BA9 | P value |
---|---|---|---|---|
n = 17 | n = 51 | n = 71 | ||
Age in months, median [IQR] | 10 [3–19] | 6 [3–11] | 11 [5–19] | 0.026* |
Males (%) | 10 (58.8) | 33 (64.7) | 41 (57.7) | 0.733** |
Days between illness onset and specimen collection, median [IQR] | 4 [3–5] | 5 [4–7] | 4 [3–7] | 0.074* |
Symptoms (%) | ||||
Fever | 13 (76.5) | 39 (76.5) | 61 (85.9) | 0.361** |
Cough | 17 (100.0) | 51 (100.0) | 71 (100.0) | - |
Chest indrawing | 17 (100.0) | 51 (100.0) | 71 (100.0) | - |
Difficulty of breathing | 12 (70.6) | 41 (80.4) | 50 (70.4) | 0.436** |
Inability of drink | 0 (0.0) | 1 (2.0) | 5 (7.0) | 0.255** |
Neurological signs | 0 (0.0) | 5 (9.8) | 5 (7.4) | 0.398** |
Peripheral oxygen saturation < 90 % (%) | 1 (5.9) | 6 (11.8) | 11 (15.5) | 0.542** |
Viral coinfection (%) | 0 (0.0) | 7 (13.7) | 4 (8.4) | 0.114** |
Viral load (Log10 RNA copies/μL), median [IQR] | ||||
All ages | 6.5 [5.8–6.8] | 5.4 [4.6–6.2] | 5.4 [4.8–6.1] | <0.001*** |
< 6 months | (n = 6) | (n = 27) | (n = 21) | |
6.6 [6.2–7.2] | 5.7 [4.7–6.4] | 5.8 [5.2–6.2] | 0.032* |